Patience Browne

Patience Browne

Auto-generated profile, based on publicly available information

Patience Browne

Organization for Economic Cooperation and Development, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2019 in Nature Reviews Endocrinology
Verified
Journal Article
Open access
PDF file
MMMichele A. La Merrill
Michele A. La Merrill
LVLaura N. Vandenberg
Laura N. Vandenberg
MSMartyn T. Smith
Martyn T. Smith
WGWilliam Goodson
William Goodson
PBPatience Browne
Patience Browne
RZR. Thomas Zoeller
R. Thomas Zoeller
Endocrine-disrupting chemicals (EDCs) are exogenous chemicals that interfere with hormone action, thereby increasing the risk of adverse health outcomes, including cancer, reproductive impairment, cognitive deficits and obesity. A complex literature of mechanistic studies provides evidence on the hazards of EDC exposure, yet there is no widely accepted systematic method to integrate these data to help identify EDC hazards. Inspired by work to improve hazard identification of carcinogens using key characteristics (KCs), we have developed ten KCs of EDCs based on our knowledge of hormone actions and EDC effects. In this Expert Consensus Statement, we describe the logic by which these KCs are identified and the assays that could be used to assess several of these KCs. We reflect on how these ten KCs can be used to identify, organize and utilize mechanistic data when evaluating chemicals as EDCs, and we use diethylstilbestrol, bisphenol A and perchlorate as examples to illustrate this approach.

22 September 2017 in Environmental Health Perspectives
Verified
Journal Article
Open access
PBPatience Browne
Patience Browne
PNPamela D. Noyes
Pamela D. Noyes
WCWarren M. Casey
Warren M. Casey
DDDavid J. Dix
David J. Dix
A peer-reviewed open access journal published by the National Institute of Environmental Health Sciences

1 March 2020 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
PBPatience Browne
Patience Browne
LWLeon Van Der Wal
Leon Van Der Wal
AGAnne Gourmelon
Anne Gourmelon

1 February 2024 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Open access
PBPatience Browne
Patience Browne
KFKatie Paul Friedman
Katie Paul Friedman
KBKim Boekelheide
Kim Boekelheide
RTRussell S. Thomas
Russell S. Thomas
Chemical safety assessment begins with defining the lowest level of chemical that alters one or more measured endpoints. This critical effect level, along with factors to account for uncertainty, is used to derive limits for human exposure. In the absence of data regarding the specific mechanisms or biological pathways affected, non-specific endpoints such as body weight and non-target organ weight changes are used to set critical effect levels. Specific apical endpoints such as impaired reproductive function or altered neurodevelopment have also been used to set chemical safety limits; however, in test guidelines designed for specific apical effect(s), concurrently measured non-specific endpoints may be equally or more sensitive than specific endpoints. This means that rather than predicting a specific toxicological response, animal data are often used to develop protective critical effect levels, without assuming the same change would be observed in humans. This manuscript is intended to encourage a rethinking of how adverse chemical effects are interpreted: non-specific endpoints from in vivo toxicological studies data are often used to derive points of departure for use with safety assessment factors to create recommended exposure levels that are broadly protective but not necessarily target-specific.

1 October 2018 in Reproductive Toxicology
Verified
Journal Article
Closed access
PBP. Browne
P. Browne
NKN.C. Kleinstreuer
N.C. Kleinstreuer
PCP. Ceger
P. Ceger
CDChad Deisenroth
Chad Deisenroth
NBN. Baker
N. Baker
WCW. Casey
W. Casey

31 August 2024 in Environment International
Verified
Journal Article
Open access
NHNancy B. Hopf
Nancy B. Hopf
Christophe RousselleChristophe Rousselle
Christophe Rousselle
DPDevika Poddalgoda
Devika Poddalgoda
FLFarida Lamkarkach
Farida Lamkarkach
JBJos Bessems
Jos Bessems
RPRobert Pasanen-Kase
Robert Pasanen-Kase
Biomonitoring has been widely used in assessing exposures in both occupational and public health complementing chemical risk assessments because it measures the concentrations of chemical substances in human body fluids (e.g., urine and blood). Biomonitoring considers all routes and sources of exposure. An occupational biomonitoring guidance document has been elaborated (OECD Occupational Biomonitoring Guidance) within the OECD framework and specifically, the Working Parties on Exposure and Hazard Assessment by scientific experts from 40 institutes and organizations representing 15 countries. The guidance provides practical information for assessing chemical exposures in occupational settings including the three common routes of exposure: inhalation, skin absorption and ingestion due to hand to mouth contact. The elaborated stepwise approach for conducting biomonitoring is tailored for occupational health professionals, scientists, risk assessors, and regulators. It includes methods for selecting appropriate biomarkers, devising sampling strategies, and assessing laboratories for validated analytical methods for the biomarker of interest, and ensuring timely feedback of results. Furthermore, it describes procedures for setting up efficient biomonitoring programs based on the Similar Exposure Group (SEG) approaches. Derived health-based human exposure biomarker assessment values called Occupational Biomonitoring Levels (OBLs) are proposed for use in occupational exposure and risk assessment. It also helps with the interpretation of biomonitoring results routinely collected and procedures for communicating biomonitoring results at individual, collective, and workplace levels. Ethical considerations associated with biomonitoring are also discussed. The ultimate goal of this biomonitoring approach is to promote harmonized application and interpretation of biomarkers as well as evidence-based occupational risk management measures.